Pfizer Inc. news

   Watch this stock
Showing stories 11 - 20 of about 182   

Articles published

PFE 30.40 -0.18 (-0.59%)
price chart
SunTrust Sees Further Pfizer Inc. Bid For AstraZeneca PLC (ADR) 'Highly Likely'
Pfizer Inc. (NYSE: PFE) is likely to boost its offer for British drug maker AstraZeneca PLC (ADR) (NYSE: AZN) to $96.28 a share, an analyst said Tuesday.
AstraZeneca Bullish Options Gain on Pfizer Comeback Bets  Bloomberg
AstraZeneca is tougher Pfizer target as possible bid looms  Bangor Daily News
Related articles »  
Pfizer CEO Is Still Weighing Inversion Deals
Mr. Read wouldn't comment on whether Pfizer will revisit its bid once it's allowed to do so under U.K. takeover laws, but he did make crystal clear that the company is considering a number of ways to move its headquarters overseas to lower its tax rate ...
Market Movers : JPMorgan Chase & Co. (NYSE:JPM), Pfizer Inc. (NYSE:PFE ...
Banks and credit unions are starting to proactively reissue credit cards and debit cards to customers whose accounts may have been exposed to a data breach at Home Depot Inc. J.P. Morgan Chase & Co. (NYSE:JPM), regional lender Huntington Bancshares ...
Pfizer Inc. Trying To Claw Its Way Back Up After Pullback
Do the company's fundamentals call for higher prices? Pfizer shareholders, like so many in the big pharma sector, long for the days of �explosive growth� when the company was releasing its then-new wonder drug, Viagra. Now, it seems as though ...
Key Growth Drivers For Pfizer Inc.
ENBREL was released as a co-promotion campaign by Pfizer and Amgen, Inc. (AMGN) last year. Pfizer's rights to ENBREL expired last year, after which it went back to Amgen.
Pfizer Signs Agreement To Market Novartis' Respiratory Inhalers In UK
Pfizer Inc. (PFE) has entered into an agreement with Novartis AG (ADR) (NVS), under which Pfizer's UK-based business, officially named Pfizer Limited, will be responsible for the commercialization of Novartis' two respiratory inhalers, Seebri ...
Vectura Says Pfizer To Commercialize Two Treatments In UK  London South East
Related articles »  
Pfizer, Merck to Team Up on Lung-Cancer Study
Pharmaceutical companies are jockeying for position in the rapidly growing cancer-treatment market. Immunotherapy, which uses immune systems to fight the disease, is driving much of the expansion.
Pfizer to test Xalkori lung cancer drug with Merck immunotherapy  Reuters UK
Related articles »  
AstraZeneca rises as investors bet on revival of Pfizer deal
According to reports July 29, 2014, Pfizer Inc.. the second-largest U.S. pharmaceutical maker, posted a 79 percent drop in second quarter profits, but beat analyst expectations.
U.K. Stocks Rise as AstraZeneca Gains on Pfizer Report  Bloomberg
AstraZeneca And Pfizer Can Commence Merger Talks Again  Bidness ETC
Related articles »  
Hot Stock List : Pfizer Inc. (NYSE:PFE), Yelp, Inc. (NYSE:YELP), Guess' Inc ...
Pfizer Inc. (NYSE:PFE), which has pursued tax inversion transactions, has received a total of $48.28 million in BEIP and other incentives.
Related articles »  
Pfizer: You Won't Fool Me Twice
Pfizer (NYSE:PFE) tried to buy up AstraZeneca (NYSE:AZN) back in May in an effort to take advantage of the tax inversion craze.
Related articles »